# PlushCare reviews (2026): GLP-1 telehealth sellers | This GLP The advertised cash-pay figure buys the 0.25 mg starting dose, and every maintenance dose is priced above it. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/plushcare Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Starting dose only at $149 # PlushCare review The advertised cash-pay figure buys the 0.25 mg starting dose, and every maintenance dose is priced above it. ## The verdict PlushCare advertises compounded semaglutide at $149 a month cash-pay, and that figure covers the 0.25 mg starting dose only. Every higher dose is $299. No compounded tirzepatide price is published, and insurance is accepted on a separate basis. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection States 50 From From $149/mo Prescription Required Compounded Yes — not FDA-approved PlushCare sells compounded semaglutide as a weekly injection across fifty states. The cash-pay figures read $149 at 0.25 mg and $299 at every dose from 0.5 mg to 2.4 mg. Its compounded tirzepatide page now redirects to a Mounjaro page with no compounded price. Insurance is accepted as a separate route to treatment. 1. ## Who writes the prescription, and what do they see? Treatment runs through a clinician visit rather than a form alone, and insurance is billed where it applies. That is a different model from a flat-fee compounding seller with no visit in it. What the visit covers, and how often it repeats, is not published. The two routes are priced separately and a reader chooses one at intake. Care is arranged remotely and the prescription follows the visit. The cash-pay figure and the insurance route answer different questions for different readers. A reader with coverage is comparing a copay against $149 rather than comparing sellers. A reader without coverage is comparing $149 against a market where most rates are flat. 2. ## What happens when the dose goes up? This is the seller's weak point and it is stated plainly. $149 buys 0.25 mg, and 0.25 mg is a four-week starting dose for almost everyone. Every dose from 0.5 mg to 2.4 mg is $299, printed in the same sentence as the entry figure. A reader planning a year should treat $149 as the first month and $299 as the standing rate. 3. ## What the price includes $149 is real and it is narrow. Sellers charging a flat $199 hold that figure at 2.4 mg, where PlushCare charges $299. No compounded tirzepatide figure is published at all. Insurance may change the semaglutide figure and is settled case by case rather than published. 4. ## What it claims, and what it cites The [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) is compounded, so a pharmacy prepares it and no regulator reviews the finished vial. The published weight-change results for semaglutide came from the approved product at maintenance doses, not at 0.25 mg. A starting dose is a titration step rather than a treatment dose. What four weeks at 0.25 mg produces on its own was not measured as an endpoint. ## Where it holds up, and where it does not - Strength: Says what the entry figure buys - Strength: Insurance accepted as a separate route - Strength: Prescription follows a clinician visit - Limitation: Maintenance doses cost $299 a month - Limitation: No compounded tirzepatide price published ## What the evidence says about this kind of treatment The assessment above is about PlushCare. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader with insurance who wants a clinician visit in the loop, and who reads $149 as a starting-dose figure rather than a standing one. Wrong for A reader budgeting a year at one rate, because the advertised figure covers 0.25 mg and every dose above it is $299. ## The evidence behind what PlushCare prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How PlushCare compares | Seller | Who it suits | Go | | --- | --- | --- | | Liberty | A reader who wants to know what kind of facility made the vial, and will accept a mid-market rate to get that in writing. | | | Pallas Health | A reader past the opening quarter who wants check-ins priced in, not billed per visit. | | | Harper Meds | A reader who wants a clinician, a prescription and the medication under one charge, with no term to commit to before reaching the published rate. | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Vitakey](https://thisglp.com/reviews/vitakey) [Vital Step](https://thisglp.com/reviews/vital-step) [Vivanta Care](https://thisglp.com/reviews/vivanta-care) [VivioMD](https://thisglp.com/reviews/viviomd) [welludr.](https://thisglp.com/reviews/wellmedr)[Yes Clinic](https://thisglp.com/reviews/yes-clinic) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is $149 what a maintenance dose costs? No. PlushCare states that the $149 cash-pay figure buys the 0.25 mg starting dose, and that 0.5 mg through 2.4 mg cost $299 a month. How long does anyone stay at 0.25 mg? The approved semaglutide schedule holds 0.25 mg for four weeks before the first increase. A reader on that schedule is past the advertised figure by month two. Does insurance change the price? Insurance is accepted on a separate basis from the cash-pay figure, and what it leaves a patient to pay is settled case by case rather than published. Is PlushCare expensive compared with other GLP-1 telehealth sellers? PlushCare publishes a starting figure of $149/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts PlushCare below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).